Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (497) Periostat (doxycycline hyclate), CollaGenex Pharmaceuticals,
...Newly Approved Drug Therapies (497) Periostat (doxycycline hyclate), CollaGenex Pharmaceuticals, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Periostat (doxycycline hyclate) Company: CollaGenex Pharmaceuticals Approval Status: Approved October 1998 Treatment Area: Dental General Information Periostat ...
View Page

2.  Newly Approved Drug Therapies (677) Periostat (doxycycline hyclate), CollaGenex Pharmaceuticals,
...Newly Approved Drug Therapies (677) Periostat (doxycycline hyclate), CollaGenex Pharmaceuticals, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Periostat (doxycycline hyclate) Company: CollaGenex Pharmaceuticals Approval Status: Approved February 2001 Treatment Area: Periodontal disease General Information ...
View Page

3.  Newly Approved Drug Therapies (527) Atridox, Atrix Laboratories,
...DL-lactide) (PLA) dissolved in 63.3% N-methyl-2-pyrrolidone (NMP). Syringe B contains doxycycline hyclate which is equivalent to 42.5 mg doxycycline. The constituted product is a pale yellow to yellow viscous liquid with a concentration of ...
View Page

4.  CenterWatch: Dental/Maxillofacial Surgery Approved Drug Therapies
...in 2001 Arestin (minocycline hydrochloride) ; OraPharma; For treatment of adult periodontitis, Approved February 2001 Periostat (doxycycline hyclate) ; CollaGenex Pharmaceuticals; Oral tablet for adjunctive treatment of adult periodontitis, Approved February 2001 Drugs ...
...Drugs Approved in 1998 Atridox ; Atrix Laboratories; Treatment for periodontal disease, Approved September 1998 Periostat (doxycycline hyclate) ; CollaGenex Pharmaceuticals; Treatment for periodontitis., Approved October 1998 Drugs Approved in 1997 Aphthasol ; Block ...
View Page

5.  Study Posting (799) Trial #153246, Rosacea, Boston, MA
...15% gel twice daily or metronidazole topical gel 1% once daily, plus anti-inflammatory dose doxycycline (40 mg) once daily in subjects with moderate papulopustular rosacea Do you have Rosacea? You ...
...15% gel twice daily or metronidazole topical gel 1% once daily, plus anti-inflammatory dose doxycycline (40 mg) once daily in subjects with moderate papulopustular rosacea Rosacea Boston, MA 153246 Clinical ...
View Page

6.  Study Posting (4519) Trial #118353, Non-Small Cell Lung Cancer, Vannes, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open label study to evaluate the effect of doxycycline on Tarceva-induced skin rash in patients with non-small cell lung cancer after failure ...
...failed first-line chemotherapy for advanced disease. Eligible patients will be randomized to receive a)doxycycline 100mg po daily or b)no preventative treatment; all patients will receive Tarceva 150mg/kg ...
View Page

7.  Study Posting (4519) Trial #133792, Non-Small Cell Lung Cancer, Tours, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open label study to evaluate the effect of doxycycline on Tarceva-induced skin rash in patients with non-small cell lung cancer after failure ...
...failed first-line chemotherapy for advanced disease. Eligible patients will be randomized to receive a)doxycycline 100mg po daily or b)no preventative treatment; all patients will receive Tarceva 150mg/kg ...
View Page

8.  Study Posting (4519) Trial #118260, Non-Small Cell Lung Cancer, Rouen, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open label study to evaluate the effect of doxycycline on Tarceva-induced skin rash in patients with non-small cell lung cancer after failure ...
...failed first-line chemotherapy for advanced disease. Eligible patients will be randomized to receive a)doxycycline 100mg po daily or b)no preventative treatment; all patients will receive Tarceva 150mg/kg ...
View Page

9.  Study Posting (4519) Trial #118278, Non-Small Cell Lung Cancer, Rennes, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open label study to evaluate the effect of doxycycline on Tarceva-induced skin rash in patients with non-small cell lung cancer after failure ...
...failed first-line chemotherapy for advanced disease. Eligible patients will be randomized to receive a)doxycycline 100mg po daily or b)no preventative treatment; all patients will receive Tarceva 150mg/kg ...
View Page

10.  Study Posting (4519) Trial #118348, Non-Small Cell Lung Cancer, Pontoise, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open label study to evaluate the effect of doxycycline on Tarceva-induced skin rash in patients with non-small cell lung cancer after failure ...
...failed first-line chemotherapy for advanced disease. Eligible patients will be randomized to receive a)doxycycline 100mg po daily or b)no preventative treatment; all patients will receive Tarceva 150mg/kg ...
View Page

11.  Study Posting (4519) Trial #120151, Non-Small Cell Lung Cancer, Perpignan, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open label study to evaluate the effect of doxycycline on Tarceva-induced skin rash in patients with non-small cell lung cancer after failure ...
...failed first-line chemotherapy for advanced disease. Eligible patients will be randomized to receive a)doxycycline 100mg po daily or b)no preventative treatment; all patients will receive Tarceva 150mg/kg ...
View Page

12.  Study Posting (4519) Trial #118355, Non-Small Cell Lung Cancer, Perigueux, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open label study to evaluate the effect of doxycycline on Tarceva-induced skin rash in patients with non-small cell lung cancer after failure ...
...failed first-line chemotherapy for advanced disease. Eligible patients will be randomized to receive a)doxycycline 100mg po daily or b)no preventative treatment; all patients will receive Tarceva 150mg/kg ...
View Page

13.  Study Posting (4519) Trial #118238, Non-Small Cell Lung Cancer, Paris, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open label study to evaluate the effect of doxycycline on Tarceva-induced skin rash in patients with non-small cell lung cancer after failure ...
...failed first-line chemotherapy for advanced disease. Eligible patients will be randomized to receive a)doxycycline 100mg po daily or b)no preventative treatment; all patients will receive Tarceva 150mg/kg ...
View Page

14.  Study Posting (4519) Trial #120160, Non-Small Cell Lung Cancer, Nimes, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open label study to evaluate the effect of doxycycline on Tarceva-induced skin rash in patients with non-small cell lung cancer after failure ...
...failed first-line chemotherapy for advanced disease. Eligible patients will be randomized to receive a)doxycycline 100mg po daily or b)no preventative treatment; all patients will receive Tarceva 150mg/kg ...
View Page

15.  Study Posting (4519) Trial #118277, Non-Small Cell Lung Cancer, Metz, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open label study to evaluate the effect of doxycycline on Tarceva-induced skin rash in patients with non-small cell lung cancer after failure ...
...failed first-line chemotherapy for advanced disease. Eligible patients will be randomized to receive a)doxycycline 100mg po daily or b)no preventative treatment; all patients will receive Tarceva 150mg/kg ...
View Page

16.  Study Posting (4519) Trial #118235, Non-Small Cell Lung Cancer, Limoges, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open label study to evaluate the effect of doxycycline on Tarceva-induced skin rash in patients with non-small cell lung cancer after failure ...
...failed first-line chemotherapy for advanced disease. Eligible patients will be randomized to receive a)doxycycline 100mg po daily or b)no preventative treatment; all patients will receive Tarceva 150mg/kg ...
View Page

17.  Study Posting (4519) Trial #133883, Non-Small Cell Lung Cancer, Gleize, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open label study to evaluate the effect of doxycycline on Tarceva-induced skin rash in patients with non-small cell lung cancer after failure ...
...failed first-line chemotherapy for advanced disease. Eligible patients will be randomized to receive a)doxycycline 100mg po daily or b)no preventative treatment; all patients will receive Tarceva 150mg/kg ...
View Page

18.  Study Posting (4519) Trial #126872, Non-Small Cell Lung Cancer, Gap, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open label study to evaluate the effect of doxycycline on Tarceva-induced skin rash in patients with non-small cell lung cancer after failure ...
...failed first-line chemotherapy for advanced disease. Eligible patients will be randomized to receive a)doxycycline 100mg po daily or b)no preventative treatment; all patients will receive Tarceva 150mg/kg ...
View Page

19.  Study Posting (4519) Trial #118354, Non-Small Cell Lung Cancer, Draguignan, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open label study to evaluate the effect of doxycycline on Tarceva-induced skin rash in patients with non-small cell lung cancer after failure ...
...failed first-line chemotherapy for advanced disease. Eligible patients will be randomized to receive a)doxycycline 100mg po daily or b)no preventative treatment; all patients will receive Tarceva 150mg/kg ...
View Page

20.  Study Posting (4519) Trial #118272, Non-Small Cell Lung Cancer, Chartres, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open label study to evaluate the effect of doxycycline on Tarceva-induced skin rash in patients with non-small cell lung cancer after failure ...
...failed first-line chemotherapy for advanced disease. Eligible patients will be randomized to receive a)doxycycline 100mg po daily or b)no preventative treatment; all patients will receive Tarceva 150mg/kg ...
View Page